Related Experiment Videos
Monoclonal antibodies recognizing normal human T lymphocytes and malignant human B lymphocytes: a comparative study
Journal of Immunology (Baltimore, Md. : 1950)
|November 1, 1981
Summary
This study compared eight monoclonal antibodies recognizing T cell and malignant B cell antigens. Seven antibodies target the same molecule, while one recognizes a distinct cell-surface molecule, aiding antibody characterization.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Murine monoclonal antibodies are crucial tools in immunology.
- Characterizing antibodies targeting shared antigens on T cells and malignant B cells is vital for diagnostics and therapeutics.
- Existing antibody characterizations can present discrepancies due to methodological variations.
Purpose of the Study:
- To directly compare eight murine monoclonal antibodies against shared T cell and malignant B cell antigens.
- To determine if these antibodies recognize the same or distinct antigenic determinants.
- To clarify the molecular associations of these cell-surface antigens.
Main Methods:
- Immune precipitation was used to isolate and analyze antigen-antibody complexes.
- Lysostripping techniques were employed to remove cell-surface antigens.
- Competitive binding assays were performed to assess antibody cross-reactivity and binding affinities.
Main Results:
- Seven monoclonal antibodies (Leu 1, T101, 17F12, SC1, A50, OKT1, and 10.2) recognized antigenic determinants that are closely associated on the same molecular species, potentially identical.
- One antibody (12.1) identified an antigenic determinant present on a distinct cell-surface molecule.
- Quantitative direct comparison resolved apparent discrepancies in antibody characterization.
Conclusions:
- Direct, quantitative comparison of monoclonal antibodies is essential for accurate characterization.
- Seven of the tested antibodies recognize the same or highly similar cell-surface antigen.
- Antibody 12.1 recognizes a different cell-surface molecule, highlighting the heterogeneity of antigens targeted by T cell and malignant B cell antibodies.